Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net income (loss)	$ (1,314)	$ 56,180
Adjustments for noncash items:
Depreciation	22,272	25,072
Amortization of identifiable intangibles	3,076	4,550
Goodwill, Impairment Loss	46,792	0
Payment for Pension and Other Postretirement Benefits	(7,182)	(4,642)
Deferred income taxes	1,152	(104)
Accrued pension and post-retirement benefits	7,809	7,645
(Gain)/loss on investment in kaléo accounted for under the fair value method	(11,900)	(24,800)
(Gain)/loss on asset impairments and divestitures	185	50
Gain (Loss) on Disposition of Assets	(86)	412
Changes in assets and liabilities, net of effects of acquisitions and divestitures:
Accounts and other receivables	(13,020)	(16,925)
Inventories	(9,204)	(4,220)
Income taxes recoverable/payable	25,912	(603)
Prepaid expenses and other	(1,655)	129
Accounts payable and accrued expenses	29,452	8,674
Other, net	705	2,093
Net cash provided by operating activities	92,994	53,511
Cash flows from investing activities:
Capital expenditures	(25,078)	(37,245)
Acquisition, net of cash acquired	0	(87,110)
Payment for Contingent Consideration Liability, Investing Activities	4,250
Escrow Deposit Disbursements Related to Property Acquisition		0
Proceeds from the sale of assets and other	1,108	121
Net cash used in investing activities	(19,720)	(124,234)
Cash flows from financing activities:
Borrowings	34,750	173,250
Debt principal payments	(95,750)	(91,250)
Dividends paid	(10,943)	(10,901)
Proceeds from exercise of stock options and other	1,004	695
Net cash provided by (used in) financing activities	(70,939)	71,794
Effect of exchange rate changes on cash	(2,050)	1,268
Increase (decrease) in cash and cash equivalents	285	2,339
Cash and cash equivalents at beginning of period	36,491	29,511
Cash and cash equivalents at end of period	$ 36,776	$ 31,850